Colonnade Acquisition Corp II (CLAA) 10-Q 25 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	May 25, 2022
Document Information [Line Items]
Document Type	10-Q
Document Period End Date	Mar. 31, 2022
Amendment Flag	false
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Registrant Name	COLONNADE ACQUISITION CORP. II
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001837739
Entity Address, State or Province	FL
Document Quarterly Report	true
Document Transition Report	false
Entity Shell Company	true
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity File Number	001-40184
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	1400 Centrepark Blvd
Entity Address, Address Line Two	Ste 810
Entity Address, City or Town	West Palm Beach
Entity Address, Postal Zip Code	33401
Entity Tax Identification Number	00-0000000
City Area Code	561
Local Phone Number	712-7860
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-fifth of one redeemable warrant
Trading Symbol	CLAA.U
Security Exchange Name	NYSE
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
Trading Symbol	CLAA WS
Security Exchange Name	NYSE
Common Class A [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A Ordinary Shares, par value $0.0001 per share
Trading Symbol	CLAA
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		33,000,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		8,250,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 109,674	$ 299,837
Prepaid expenses	634,918	630,813
Total current assets	744,592	980,650
Prepaid expenses – non-current portion		125,763
Cash and marketable securities held in trust account	330,174,862	330,082,791
Total assets	330,919,454	331,189,204
Current liabilities:
Accounts payable and accrued expenses	4,922,619	3,313,965
Promissory Note – related party	250,000
Total current liabilities	5,172,619	3,313,965
Warrant Liabilities	5,169,040	9,024,880
Deferred underwriters' discount	10,657,500	10,657,500
Total liabilities	20,999,159	22,996,345
Commitments and Contingencies (Note 6)
Class A Ordinary Shares subject to possible redemption 33,000,000 at redemption value of $10	330,000,000	330,000,000
Shareholders' deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	0	0
Accumulated deficit	(20,080,530)	(21,807,966)
Total shareholders' deficit	(20,079,705)	(21,807,141)
Total liabilities, redeemable ordinary shares and shareholders' deficit	330,919,454	331,189,204
Common Class A [Member]
Current liabilities:
Class A Ordinary Shares subject to possible redemption 33,000,000 at redemption value of $10	330,000,000	330,000,000
Shareholders' deficit:
Common stock value	0	0
Common Class B [Member]
Shareholders' deficit:
Common stock value	$ 825	$ 825

Condensed Balance Sheets (Par

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Temporary equity shares outstanding	33,000,000	33,000,000
Preferred stock par value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Temporary equity shares outstanding	33,000,000	33,000,000
Temporary Equity, Redemption Price Per Share	$ 10	$ 10
Common stock par value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	500,000,000	500,000,000
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Common Class B [Member]
Common stock par value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	50,000,000	50,000,000
Common stock shares issued	8,250,000	8,250,000
Common stock shares outstanding	8,250,000	8,250,000

Condensed Statements of Oper

Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Formation and operating costs	$ 2,220,475	$ 46,063
Loss from operations	(2,220,475)	(46,063)
Other Income (Expense)
Interest income earned on Trust Account	92,071	5,350
Change in fair value of Warrant liabilities	3,855,840	550,667
Offering costs allocated to Warrants		(475,053)
Total other income, net	3,947,911	80,964
Net income	$ 1,727,436	$ 34,901
Class A ordinary shares subject to possible redemption [Member]
Other Income (Expense)
Weighted average shares outstanding	33,000,000	33,000,000
Basic and diluted net income per share	$ 0.04	$ 0
Common Class B [Member]
Other Income (Expense)
Weighted average shares outstanding	8,250,000	7,660,112
Basic and diluted net income per share	$ 0.04	$ 0

Condensed Statements of Chan

Condensed Statements of Changes in Shareholders' Deficit - USD ($)	Total	Common Stock [Member]Common Class A [Member]	Common Stock [Member]Common Class B [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2020	$ 21,814	$ 0	$ 863	$ 24,137	$ (3,186)
Beginning balance, Shares at Dec. 31, 2020		0	8,625,000
Sponsor forfeiture of shares			$ (38)	38
Sponsor forfeiture of shares, Shares			(375,000)
Remeasurement for Class A Ordinary Shares subject to redemption	(25,558,349)			(24,175)	(25,534,174)
Net income	34,901				34,901
Ending balance at Mar. 31, 2021	(25,501,634)	$ 0	$ 825	0	(25,502,459)
Ending balance, Shares at Mar. 31, 2021		0	8,250,000
Beginning balance at Dec. 31, 2021	(21,807,141)	$ 0	$ 825	0	(21,807,966)
Beginning balance, Shares at Dec. 31, 2021		0	8,250,000
Net income	1,727,436				1,727,436
Ending balance at Mar. 31, 2022	$ (20,079,705)	$ 0	$ 825	$ 0	$ (20,080,530)
Ending balance, Shares at Mar. 31, 2022		0	8,250,000

Condensed Statements of Cash

Condensed Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 1,727,436	$ 34,901
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on Trust Account	(92,071)	(5,350)
Change in fair value of Warrant liabilities	(3,855,840)	(550,667)
Offering costs allocated to Warrants		475,053
Changes in current assets and current liabilities:
Prepaid assets	171,658	(1,336,212)
Accounts payable	1,608,654	40,000
Net cash used in operating activities	(440,163)	(1,342,275)
Cash Flows from Investing Activities:
Investment of cash into trust account	0	(330,000,000)
Net cash used in investing activities	0	(330,000,000)
Cash Flows from Financing Activities:
Proceeds from Initial Public Offering, net of underwriters' discount	0	323,910,000
Proceeds from issuance of Private Placement Warrants	0	8,600,000
Proceeds from issuance of promissory note to related party	250,000	115,824
Repayment of promissory note to related party	0	(145,824)
Payments of offering costs	0	(437,755)
Net cash provided by financing activities	250,000	332,042,245
Net Change in Cash	(190,163)	699,970
Cash - Beginning	299,837	25,000	$ 25,000
Cash - Ending	109,674	724,970	$ 299,837
Supplemental Disclosure of Non-cash Financing Activities:
Deferred underwriting commissions payable	$ 0	$ 10,657,500

Organization and Business Opera

Organization and Business Operations	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business Operations	Note 1 — Organization and Business Operations Organization and General Colonnade Acquisition Corp. II (the “Company”) was incorporated in Cayman Islands on November 24, 2020. The Company was formed for the purpose of entering into a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has selected December 31 as its fiscal year end. As of March 31, 2022, the Company had not yet commenced any operations. All activity through March 31, 2022, relates to the Company’s formation and the Initial Public Offering (the “IPO” or “Initial Public Offering”) described below, and after the Initial Public Offering, to seeking a target for its initial business combination, at the earliest. The Company will not generate any operating revenues until after the completion of its initial Business combination, at the earliest. The Company will generate non-operating Financing The registration statement for the Company’s IPO was declared effective on March 9, 2021 (the “Effective Date”). On March 12, 2021, the Company consummated the IPO of 33,000,000 units (the “Units” and, with respect to the Class A Ordinary Shares included in the Units offered in the IPO, the “Public Shares”), including the partial exercise by the underwriters of their over-allotment option, at Simultaneously with the closing of the IPO, the Company consummated the sale (the “Private Placement”) of 5,733,333 warrants (the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant, which is discussed in Note 4. Transaction costs amounted to $17,212,069 consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs. Of the total transaction cost, $475,053 was expensed as non-operating expenses in the statements of operations with the rest of the offering cost charged to temporary equity. The transaction costs were allocated between the Public Warrant liabilities, Private Placement Warrant liabilities, and the Class A Ordinary Shares (as discussed in Note 2). Trust Account Following the closing of the IPO on March 15, 2021, an amount of $330,000,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), which is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its tax obligations, the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of our initial Business combination, (ii) the redemption of our Public Shares if we are unable to complete our initial Business combination by March 12, 2023, subject to applicable law, or (iii) the redemption of our Public Shares properly submitted in connection with a shareholder vote to amend our amended and restated memorandum and articles of association to (A) modify the substance or timing of our obligation to allow redemption in connection with our initial Business combination or to redeem of our Public Shares if we have not consummated an initial Business combination by or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s Public Shareholders. Initial Business combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all the net proceeds are intended to be generally applied toward consummating a Business combination. The rules of the New York Stock Exchange require that the Company must consummate an initial Business combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in trust) at the time of the Company’s signing a definitive agreement in connection with its initial Business combination. However, the Company will only complete such Business combination if the post transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business combination. The Company will provide its P S The ordinary shares subject The Company will have until March 12, 2023 (with the ability to extend with shareholder approval) to consummate a Business combination (the “Combination Period”). However, if the Company is unable to complete a Business combination within the Combination Period, the Company will redeem 100% of the outstanding Public Shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of our initial Business combination, including interest earned on the funds held in the Trust Account and not previously released to the Company, divided by the number of then outstanding Public Shares, subject to applicable law and as further described in the registration statement, and then seek to dissolve and liquidate. The Company’s sponsor, Colonnade Sponsor II LLC (the “Sponsor”), officers and directors have agreed to (i) waive their redemption rights with respect to the 7,187,500 Class B Ordinary Shares issued to the Sponsor for an aggregate purchase price of $25,000 on December 31, 2020 (the “Founder Shares”) and Public Shares in connection with the completion of the initial Business combination, (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business combination or to redeem of its Public Shares if it has not consummated an initial Business combination within the Combination Period or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial 8 The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations. Going Concern As of March 31, 2022, the Company had cash outside the Trust Account of $109,674 and working capital deficiency of $4,428,027. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial Business c c As of March 31, 2022, none of the amount in the Trust Account was withdrawn as described above. Through March 31, 2022, the Company’s liquidity needs were satisfied through receipt of $25,000 from the sale of the Founder Shares and the remaining net proceeds from the IPO and the sale of Private Placement Warrants. In order to fund working capital deficiencies or finance transaction costs in connection with a Business combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business combination, it would repay such loaned amounts. In the event that a Business combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from the Trust Account would be used for such repayment. Up to of such loans may be convertible into Warrants (as defined in Note 4 per Warrant at the option of the lender. The Warrants would be identical to the Private Placement Warrants. Until the consummation of a Business combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. The Company’s amended and restated memorandum and articles of association provide that the Company will have only 24 months (until March 12, 2023) from the closing of the Initial Public Offering to complete a business combination. There is no guarantee that the Company will be able to complete a business combination within the Combination Period. The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business combination or the date the Company is required to liquidate. These unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2— Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the Warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, the Company had $ in cash, respectively. The Company had no cash equivalents as of March 31, 2022 and December 31, 2021. Cash and Marketable Securities Held in Trust Account As of March 31, 2022 and December 31, 2021, the Trust Account had $330,174,862, and $330,082,791, respectively, held in primarily U.S. Treasury bills. During the three months ended March 31, 2022 and March 31, 2021, the Company did not withdraw any of the interest income from the Trust Account to pay its tax obligations. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on this account. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC 480. Class A Ordinary Shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ deficit. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in (to the extent available) capital and accumulated deficit. As of March 31, 2022 and December 31, 2021, the ordinary shares reflected on the condensed balance sheets are reconciled in the following table: Gross Proceeds $ 330,000,000 Less: Proceeds allocated to Public Warrants (9,108,000 ) Issuance costs related to Class A O S (16,737,016 ) Plus: Accretion of carrying value to redemption value 25,845,016 Contingently redeemable Class A Ordinary Shares $ 330,000,000 Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of ASC Topic 260, Earnings Per Share (“ASC 260”). The Company applies the two-class method The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the Three Months ended March 31, 2022 For the Three Months ended March 31, 2021 Redeemable Class A Ordinary Shares Numerator: Net income allocable to Class A Ordinary Shares subject to possible redemption $ 1,381,949 $ 28,326 Denominator: Weighted average redeemable Class A Ordinary Shares, Basic and Diluted 33,000,000 33,000,000 Basic and diluted net income per share, redeemable Class A Ordinary Shares $ 0.04 $ 0.00 Non-redeemable Numerator: Net income allocable to non-redeemable $ 345,487 $ 6,575 Denominator: Weighted average non-redeemable 8,250,000 7,660,112 Basic and diluted net income per share, non-redeemable $ 0.04 $ 0.00 Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to stockholders’ deficit upon the completion of the IPO. Accordingly, on June 30, 2021, offering costs totaling $ $464,569 of other offering costs). Of the total transaction cost $475,053 was charged to expense as a non-operating expense in the statements of operations with the rest of the offering cost were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase Warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. Pursuant to ASC 480 and Accounting Standards Codification 815-40, Derivatives and Hedging; The Company accounts for its 12,333,333 Warrants, including 6,600,000 Warrants issued in connection with its IPO and 5,733,333 Warrants issued as part of the Private Placement as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised or modified, and any change in fair value is recognized in the Company’s statements of operations. The fair value of Warrants issued by the Company in connection with the Initial Public Offering and Private Placement Warrants has been estimated using Monte-Carlo simulations. Subsequently, at March 31, 2022 and December 31, 2021, Public and Private Placement Warrants were valued using observable market quotes in an active market, and Monte-Carlo simulations, respectively. Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2022 and December 31, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Standards In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt (Subtopic 470-20) and (Subtopic 815-40) (“ASU 2020-06”) to ASU 2020-06 eliminates ASU 2020-06 amends the if-converted method 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering Pursuant to the IPO, the Company sold 33,000,000 Units, including the partial exercise by the underwriters of their over-allotment option, at a price of $ per Unit. Each Unit consists of one Class A Ordinary Share and one-fifth of one redeemable warrant (“Public Warrant”, and collectively with the Private Placement Warrants, the “Warrants”). Each whole Public Warrant entitles the holder to purchase one share of Class A Ordinary Share at a price of $

Private Placement Warrants

Private Placement Warrants	3 Months Ended
	Mar. 31, 2022
Warrants and Rights Note Disclosure [Abstract]
Private Placement Warrants	Note 4 — Private Placement Warrants Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,733,333 Private Placement Warrants at a price of $1.50 per warrant ($8,600,000 in the aggregate), each Private Placement Warrant is exercisable to purchase one Class A Ordinary Shares at a price of $ per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from this offering to be held in the Trust Account. The Private Placement Warrants are identical to the Warrants sold in the IPO except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A Ordinary Shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial Business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to certain registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Warrants included in the units being sold in the IPO. The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of the initial Business combination, (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business combination or to redeem 100% of the Company’s Public Shares if the Company has not consummated an initial Business combination within the Combination Period or (B) with respect to any other material provisions relating to shareholders’ rights or pre initial Business combination activity, (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete the initial Business combination within the Combination Period, and (iv) vote any Founder Shares held by the Sponsor and any Public Shares purchased during or after the IPO (including in open market and privately-negotiated transactions) in favor of the initial Business combination.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On December 31, 2020, the Company issued 7,187,500 Class B Ordinary Shares to the Sponsor for an aggregate purchase price of $ shares of Class B Ordinary Shares being issued and outstanding. The share capitalization was retroactively applied in the Company’s financial statements. Up to Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option was exercised. On March 12, 2021, the underwriter partially exercised the over-allotment option and therefore Founder Shares were forfeited, and Founder Shares were no longer subject to forfeiture, resulting in Founder Shares outstanding at March 31, 2022 and December 31, 2021. The underwriters forfeited their remaining over-allotment option on the date of the IPO. The initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares and any Class A Ordinary Shares issuable upon conversion thereof until the earlier to occur of: (i) after the completion of the initial Business combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business combination that results in all of the Company’s shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the “lock-up”). Notwithstanding the foregoing, if the closing price of Class A Ordinary Shares equals or exceeds $ per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any trading days 30 -trading day period commencing at least days after the initial Business combination or (2) if the Company consummates a transaction after the initial Business combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from the lock-up. Promissory Note — Related Party On December 17, 2020, the Sponsor agreed to loan the Company up to $ to be used for a portion of the expenses of the IPO. These loans are non-interest bearing, unsecured and are due at the earlier of December 31, 2021 or the closing of the IPO. The loan was repaid upon the closing of the Initial Public Offering out of the offering proceeds that were allocated to the payment of offering expenses. Administrative Support Agreement Commencing on the date of the IPO, the Company has agreed to pay the Sponsor a total of $ per month for rent of office space, utilities, secretarial and administrative services provided to members of the Company’s management team. Upon completion of the initial business combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three months ended March 31, 2022 and 2021, the Company has incurred $ in expense pursuant to this agreement, respectively. All outstanding fees owed are paid and thus nothing is accrued as of March 31, 2022 and 2021. Working Capital Loans In addition, in order to finance transaction costs in connection with a Business combination, the initial shareholders or an affiliate of the initial shareholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On March 24, 2022, $ 250,000 was drawn under the terms of these Working Capital Loans and was outstanding as of March 31, 2022.

Commitments & Contingencies

Commitments & Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 6 — Commitments & Contingencies Registration Rights The holders of the (i) Founder Shares, which were issued in a Private Placement prior to the closing of the IPO, (ii) Private Placement Warrants which will be issued in a Private Placement simultaneously with the closing of the IPO and the Class A Ordinary Shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of Working Capital Loans have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriters Agreement On March 12, 2021, the Company paid a fixed underwriting discount of $6,090,000. Additionally, a deferred underwriting discount of $10,657,500 will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an initial Business c

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Note 7 — Shareholders’ Deficit Preference shares each. As of March 31, 2022 and December 31, 2021, there were no preference shares issued or outstanding. Class A Ordinary Shares Class A Ordinary Shares at par value of $ each. As of March 31, 2022 and December 31, 2021, there were Class A Ordinary Shares issued and outstanding, all of which were subject to possible redemption, classified outside of shareholders’ deficit. Class B Ordinary Shares Class B Ordinary Shares at par value of $ each. As of March 31, 2022 and December 31, 2021, there were shares of Class B Ordinary Shares issued and outstanding. Holders of Class A Ordinary Shares and holders of Class B Ordinary Shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders. The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation of the initial Business combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Ordinary Shares or equity- linked securities are issued or deemed issued in connection with the initial Business combination, the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, of the total number of Class A Ordinary Shares outstanding after such conversion (after giving effect to any redemptions of Class A Ordinary Shares by Public Shareholders), including the total number of Class A Ordinary Shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business combination, excluding any Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, or to be issued, to any seller in the initial Business combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

Warrants

Warrants	3 Months Ended
	Mar. 31, 2022
Warrants and Rights Note Disclosure [Abstract]
Warrants	Note 8 — Warrants Each whole Warrant entitles the holder to purchase one Class A Ordinary Share Ordinary Share Ordinary Share Ordinary Share The Warrants will become exercisable 30 days after the completion of its initial Business combination and will expire five years after the completion of the Company’s initial Business combination, or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than twenty (20) business days after the closing of the initial Business combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement, under the Securities Act, of the Class A Ordinary Shares issuable upon exercise of the Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of the Warrant Agreement. If a registration statement covering the Class A Ordinary Shares issuable upon exercise of the Warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business combination, Warrantholders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A Ordinary Shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per Warrant; • upon not less than 30 days’ prior written notice of redemption to each Warrantholder (the “30 day redemption period”); and • if, and only if, the reported sale price of the o s days within a 30-trading day period In no event will the Company be required to net cash settle any Warrants. Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00. • in whole and not in part; • at a price of $0.10 per Warrant; • upon a minimum of 30 days’ prior written notice of redemption; provided • if, and only if, the last reported sale price of the Class A Ordinary Shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within a 30-trading day period If the Company is unable to complete the initial Business combination within the combination period and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Warrants. Accordingly, the Warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 9 — Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. The Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants should be recorded as derivative liabilities. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following tables presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, 2022 Quoted Prices In Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Description Assets: Cash and marketable securities held in Trust Account $ 330,174,862 $ 330,174,862 $ — $ — Liabilities: Warrant liabilities – Public Warrants 2,706,000 2,706,000 — — Warrant liabilities – Private Placement Warrants 2,463,040 — — 2,463,040 Total liabilitie s $ 5,169,040 $ 2,706,000 $ — $ 2,463,040 December 31, 2021 Quoted Prices In Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Description Assets: Cash and marketable securities held in Trust Account $ 330,082,791 $ 330,082,791 $ — $ — Liabilities: Warrant liabilities – Public Warrants 4,750,680 4,750,680 — — Warrant liabilities – Private Placement Warrants 4,274,200 — — 4,274,200 Total liabilitie s $ 9,024,880 $ 4,750,680 $ — $ 4,274,200 The Company’s Warrant liability for the Public Warrants is based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. The fair value of the Public Warrant liability is classified within Level 1 of the fair value hierarchy. The Company utilizes a Black Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the statements of operations. The estimated fair value of the Private Placement Warrant liability is determined using Level 3 inputs. In the third quarter of 2021, Public Warrants were reclassified from level 3 to level 1 because the Public Warrants began to trade on the New York Stock Exchange. The Company estimates the volatility of its binomial options pricing model based on historical volatility that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on The aforementioned Warrant liabilities are not subject to qualified hedge accounting. The following table provides quantitative information regarding Level 3 fair value measurements: At March 31, 2022 Warrants At December 31, 2021 Warrants Share price $ 9.77 $ 9.71 Strike price $ 11.50 $ 11.50 Term (in years) 5.0 4.25 Volatility 7.0 % 14.0 % Risk-free rate 2.55 % 1.4 % Dividend yield 0.0 % 0.0 % Redemption trigger price $ N/A $ N/A The following table provides a reconciliation of changes in fair value liability of the beginning and ending balances for the Company’s Warrants classified as Level 3: Fair value as of January 1, 2021 $ — Initial Measurement on March 12, 2021 17,421,333 Public Warrant reclassified to level 1 (1) (8,844,000 ) Change in fair value (4,303,133 ) Fair value as of December 31, 2021 4,274,200 Change in fair value (1,811,160 ) Fair value as of March 31, 2022 $ 2,463,040 (1) Assumes the Public Warrants were reclassified on March 31, 2021. The following table presents the changes in the fair value of Warrant liabilities: Public Private Warrant Fair value as of November 24, 2020 $ — $ — $ — Initial measurement on March 12, 2021 9,108,000 8,313,333 17,421,333 Change in valuation inputs or other assumptions (4,357,320 ) (4,039,133 ) (8,396,453 ) Fair value as of December 31, 2021 $ 4,750,680 $ 4,274,200 $ 9,024,880 Change in valuation inputs or other assumptions (2,044,680 ) (1,811,160 ) (3,855,840 ) Fair value as of March 31, 2022 $ 2,706,000 $ 2,463,040 $ 5,169,040

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed financial statements were issued. Based upon this review, other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements. On April 11, 2022, the Company entered into a convertible promissory note (the “2022 Note”) c c bankruptcy events. The conversion option included in the 2022 Note is considered an embedded derivative and will be remeasured at the end of each reporting period when amounts drawn under the 2022 Note will be outstanding.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the Warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, the Company had $ in cash, respectively. The Company had no cash equivalents as of March 31, 2022 and December 31, 2021.
Cash and Marketable Securities Held in Trust Account	Cash and Marketable Securities Held in Trust Account As of March 31, 2022 and December 31, 2021, the Trust Account had $330,174,862, and $330,082,791, respectively, held in primarily U.S. Treasury bills. During the three months ended March 31, 2022 and March 31, 2021, the Company did not withdraw any of the interest income from the Trust Account to pay its tax obligations.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on this account.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC 480. Class A Ordinary Shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ deficit. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in (to the extent available) capital and accumulated deficit. As of March 31, 2022 and December 31, 2021, the ordinary shares reflected on the condensed balance sheets are reconciled in the following table: Gross Proceeds $ 330,000,000 Less: Proceeds allocated to Public Warrants (9,108,000 ) Issuance costs related to Class A O S (16,737,016 ) Plus: Accretion of carrying value to redemption value 25,845,016 Contingently redeemable Class A Ordinary Shares $ 330,000,000
Net Income per Ordinary Share	Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of ASC Topic 260, Earnings Per Share (“ASC 260”). The Company applies the two-class method The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the Three Months ended March 31, 2022 For the Three Months ended March 31, 2021 Redeemable Class A Ordinary Shares Numerator: Net income allocable to Class A Ordinary Shares subject to possible redemption $ 1,381,949 $ 28,326 Denominator: Weighted average redeemable Class A Ordinary Shares, Basic and Diluted 33,000,000 33,000,000 Basic and diluted net income per share, redeemable Class A Ordinary Shares $ 0.04 $ 0.00 Non-redeemable Numerator: Net income allocable to non-redeemable $ 345,487 $ 6,575 Denominator: Weighted average non-redeemable 8,250,000 7,660,112 Basic and diluted net income per share, non-redeemable $ 0.04 $ 0.00
Offering Costs	Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to stockholders’ deficit upon the completion of the IPO. Accordingly, on June 30, 2021, offering costs totaling $ $464,569 of other offering costs). Of the total transaction cost $475,053 was charged to expense as a non-operating expense in the statements of operations with the rest of the offering cost were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase Warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. Pursuant to ASC 480 and Accounting Standards Codification 815-40, Derivatives and Hedging; The Company accounts for its 12,333,333 Warrants, including 6,600,000 Warrants issued in connection with its IPO and 5,733,333 Warrants issued as part of the Private Placement as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised or modified, and any change in fair value is recognized in the Company’s statements of operations. The fair value of Warrants issued by the Company in connection with the Initial Public Offering and Private Placement Warrants has been estimated using Monte-Carlo simulations. Subsequently, at March 31, 2022 and December 31, 2021, Public and Private Placement Warrants were valued using observable market quotes in an active market, and Monte-Carlo simulations, respectively.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2022 and December 31, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards	Recent Accounting Standards In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt (Subtopic 470-20) and (Subtopic 815-40) (“ASU 2020-06”) to ASU 2020-06 eliminates ASU 2020-06 amends the if-converted method 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Summary of basic and diluted loss per ordinary shar	For the Three Months ended March 31, 2022 For the Three Months ended March 31, 2021 Redeemable Class A Ordinary Shares Numerator: Net income allocable to Class A Ordinary Shares subject to possible redemption $ 1,381,949 $ 28,326 Denominator: Weighted average redeemable Class A Ordinary Shares, Basic and Diluted 33,000,000 33,000,000 Basic and diluted net income per share, redeemable Class A Ordinary Shares $ 0.04 $ 0.00 Non-redeemable Numerator: Net income allocable to non-redeemable $ 345,487 $ 6,575 Denominator: Weighted average non-redeemable 8,250,000 7,660,112 Basic and diluted net income per share, non-redeemable $ 0.04 $ 0.00
Summary of reconciliation of ordinary shares subject to possible redemption	Gross Proceeds $ 330,000,000 Less: Proceeds allocated to Public Warrants (9,108,000 ) Issuance costs related to Class A O S (16,737,016 ) Plus: Accretion of carrying value to redemption value 25,845,016 Contingently redeemable Class A Ordinary Shares $ 330,000,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Summary of assets measured at fair value on a recurring basis	March 31, 2022 Quoted Prices In Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Description Assets: Cash and marketable securities held in Trust Account $ 330,174,862 $ 330,174,862 $ — $ — Liabilities: Warrant liabilities – Public Warrants 2,706,000 2,706,000 — — Warrant liabilities – Private Placement Warrants 2,463,040 — — 2,463,040 Total liabilitie s $ 5,169,040 $ 2,706,000 $ — $ 2,463,040 December 31, 2021 Quoted Prices In Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Description Assets: Cash and marketable securities held in Trust Account $ 330,082,791 $ 330,082,791 $ — $ — Liabilities: Warrant liabilities – Public Warrants 4,750,680 4,750,680 — — Warrant liabilities – Private Placement Warrants 4,274,200 — — 4,274,200 Total liabilitie s $ 9,024,880 $ 4,750,680 $ — $ 4,274,200
Summary of fair value measurement inputs and valuation techniques	The following table provides quantitative information regarding Level 3 fair value measurements: At March 31, 2022 Warrants At December 31, 2021 Warrants Share price $ 9.77 $ 9.71 Strike price $ 11.50 $ 11.50 Term (in years) 5.0 4.25 Volatility 7.0 % 14.0 % Risk-free rate 2.55 % 1.4 % Dividend yield 0.0 % 0.0 % Redemption trigger price $ N/A $ N/A
Schedule of reconciliation of changes in fair value liability of warrants classified to level 3	The following table provides a reconciliation of changes in fair value liability of the beginning and ending balances for the Company’s Warrants classified as Level 3: Fair value as of January 1, 2021 $ — Initial Measurement on March 12, 2021 17,421,333 Public Warrant reclassified to level 1 (1) (8,844,000 ) Change in fair value (4,303,133 ) Fair value as of December 31, 2021 4,274,200 Change in fair value (1,811,160 ) Fair value as of March 31, 2022 $ 2,463,040 (1) Assumes the Public Warrants were reclassified on March 31, 2021.
Summary of fair value of the derivative warrant liabilities	The following table presents the changes in the fair value of Warrant liabilities: Public Private Warrant Fair value as of November 24, 2020 $ — $ — $ — Initial measurement on March 12, 2021 9,108,000 8,313,333 17,421,333 Change in valuation inputs or other assumptions (4,357,320 ) (4,039,133 ) (8,396,453 ) Fair value as of December 31, 2021 $ 4,750,680 $ 4,274,200 $ 9,024,880 Change in valuation inputs or other assumptions (2,044,680 ) (1,811,160 ) (3,855,840 ) Fair value as of March 31, 2022 $ 2,706,000 $ 2,463,040 $ 5,169,040

Organization and Business Ope_2

Organization and Business Operations - Additional Information (Detail) - USD ($)	Mar. 15, 2021	Mar. 12, 2021	Feb. 04, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from Issuance Initial Public Offering				$ 0	$ 323,910,000
Other offering costs				464,569
Cash				$ 109,674		$ 299,837
Restricted Investments Term				185 days
Percentage Of Net asset Held In The Trust Account				80.00%
Price per share				$ 10
Net tangible assets For Consummation of a Business Combination				$ 5,000,001
Public share Redeemable percentage				100.00%
Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination				100.00%
Business Combination Date				Mar. 12, 2023
Assets Held In Trust Withdrawal				$ 0
Workin capital deficiency				4,428,027
Cash [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Assets held in trust				$ 109,674
Post Business Combination Target Company [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired				50.00%
Colonnade Sponsor Llc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Condition For Future Business Combination Threshold Net Tangible Assets				$ 5,000,001
Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from Issuance Initial Public Offering				330,000,000		$ 330,000,000
Common Class B [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period value for services				$ 25,000
Sponsor [Member] | Common Class B [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period value for services							$ 7,187,500
Sponsor [Member] | Private Placement Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Warrants issued during the period		5,733,333	5,733,333
Warrants issued price per share		$ 1.5	$ 1.5
Debt Conversion, Converted Instrument, Warrants				1,500,000
Exercise Price of Warrants or Rights			$ 1	$ 1.5
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of units, Number of units Issued in Transaction		33,000,000
Sale of units, price per unit		$ 10
Proceeds from Issuance Initial Public Offering		$ 330,000,000
Transaction costs				$ 17,212,069
Underwriting fees				6,090,000
Deferred underwriting fees				10,657,500
Other offering costs				464,569
Cash				$ 475,053
IPO [Member] | Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of units, Number of units Issued in Transaction				33,000,000
Sale of units, price per unit				$ 10
Payments to Acquire Trust Preferred Investments	$ 330,000,000

Significant Accounting Polici_4

Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Cash	$ 109,674	$ 299,837
Cash Equivalents	0	0
FDIC Insured Amount	$ 250,000	$ 250,000
Temporary equity shares outstanding	33,000,000	33,000,000
Offering costs	$ 17,212,069
Underwriter Fee	6,090,000
Deferred underwriters discount	10,657,500	$ 10,657,500
Other offering costs	$ 464,569
Warrants outstanding	12,333,333
Unrecognized tax benefits	$ 0	$ 0
Unrecognized tax benefits, accrued interest and penalties	0
IPO [Member]
Cash	475,053
Other offering costs	$ 464,569
Warrants or rights issued during the period	6,600,000
Private Placement [Member]
Warrants or rights issued during the period	5,733,333
Class A Common Stock [Member]
Temporary equity shares outstanding	33,000,000	33,000,000
US Treasury Securities [Member]
Assets held in trust	$ 330,174,862	$ 330,082,791

Significant Accounting Polici_5

Significant Accounting Policies - Summary of basic and diluted loss per ordinary share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Numerator:
Net income	$ 1,727,436	$ 34,901
Redeemable Common Class A [Member]
Numerator:
Net income	$ 1,381,949	$ 28,326
Denominator:
Weighted average shares outstanding, basic and diluted	33,000,000	33,000,000
Basic and diluted net income per ordinary share	$ 0.04	$ 0
Non Redeemable Class B Ordinary Shares [Member]
Numerator:
Net income	$ 345,487	$ 6,575
Denominator:
Weighted average shares outstanding, basic and diluted	8,250,000	7,660,112
Basic and diluted net income per ordinary share	$ 0.04	$ 0

Significant Accounting Polici_6

Significant Accounting Policies - Summary of reconciliation of Ordinary shares Subject to Possible Redemption (Detail) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Temporary Equity [Line Items]
Gross Proceeds	$ 0	$ 323,910,000
Contingently redeemable Class A Ordinary Shares	330,000,000		$ 330,000,000
Common Class A [Member]
Temporary Equity [Line Items]
Gross Proceeds	330,000,000		330,000,000
Proceeds from issuance of warrants	(9,108,000)		(9,108,000)
Issuance costs related to Class A Ordinary Shares	(16,737,016)		(16,737,016)
Accretion for Class A ordinary shares subject to redemption	25,845,016		25,845,016
Contingently redeemable Class A Ordinary Shares	$ 330,000,000		$ 330,000,000

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - IPO [Member] - $ / shares	Mar. 12, 2021	Mar. 31, 2022
Sale of units, Number of units Issued in Transaction	33,000,000
Sale of units, price per unit	$ 10
Public Warrants [Member]
Class of warrant exercise price		$ 11.5
Class A Common Stock [Member]
Sale of units, Number of units Issued in Transaction		33,000,000
Sale of units, price per unit		$ 10
Sale of unit, description of transaction		Each Unit consists of one Class A Ordinary Share and one-fifth of one redeemable warrant (“Public Warrant”, and collectively with the Private Placement Warrants, the “Warrants”).
Class A Common Stock [Member] | Public Warrants [Member]
Class of warrant exercise price		$ 11.5

Private Placement Warrants - Ad

Private Placement Warrants - Additional Information (Detail) - Sponsor [Member] - Private Placement Warrants [Member] - USD ($)	Mar. 12, 2021	Feb. 04, 2021	Mar. 31, 2022
Class of Warrant or Right [Line Items]
Warrants issued during the period	5,733,333	5,733,333
Warrants issued price per share	$ 1.5	$ 1.5
Proceeds from issuance of warrants		$ 8,600,000
Class of warrant exercise price		$ 1	$ 1.5
Class of warrant exercise price per share		11.5

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Mar. 24, 2022	Mar. 12, 2021	Feb. 24, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 17, 2020
Related Party Transaction [Line Items]
Temporary equity shares outstanding				33,000,000			33,000,000
Share price				$ 10
Proceeds From Related Party Debt				$ 250,000	$ 115,824
Common Class B [Member]
Related Party Transaction [Line Items]
Stock issued during the period value for services				$ 25,000
Common stock shares outstanding				8,250,000			8,250,000
Common Stock, Shares, Issued				8,250,000			8,250,000
Administrative Support Agreement [Member]
Related Party Transaction [Line Items]
Expenses from Transactions with Related Party				$ 90,000	$ 0
Working Capital Loans [Member]
Related Party Transaction [Line Items]
Proceeds From Related Party Debt	$ 250,000
Sponsor [Member]
Related Party Transaction [Line Items]
Lock in period of shareholding				1 year
Share transfer restriction, threshold consecutive trading days				20 days
Share transfer restriction, threshold trading days				30 days
Number of days for a particular event to get over for determning trading period				150 days
Sponsor [Member] | Common Class B [Member]
Related Party Transaction [Line Items]
Stock issued during the period value for services						$ 7,187,500
Stock issued during the period shares issued for shares			1,437,500			25,000
Common stock shares outstanding						8,625,000
Temporary equity shares outstanding			1,125,000
Sponsor forfeiture of shares		$ 375,000
Number of shares no longer subject to forfeiture		750,000
Common Stock, Shares, Issued							8,250,000
Sponsor [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Unsecured promissory note, Face amount								$ 300,000
Sponsor [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Share price				$ 12
Affiliate of Sponsor [Member] | Administrative Support Agreement [Member]
Related Party Transaction [Line Items]
Payment of transaction				$ 30,000

Commitments & Contingencies - A

Commitments & Contingencies - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2022USD ($)
Commitments and Contingencies Disclosure [Abstract]
Underwriter discount	$ 6,090,000
Deferred underwriting discount non current	$ (10,657,500)

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail) - $ / shares	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock par value per share	$ 0.0001	$ 0.0001
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Temporary equity shares outstanding	33,000,000	33,000,000
IPO [Member]
Class of Stock [Line Items]
Percentage of number of shares of common stock outstanding	20.00%
Common Class A [Member]
Class of Stock [Line Items]
Common stock shares authorized	500,000,000	500,000,000
Common stock par value per share	$ 0.0001	$ 0.0001
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Temporary equity shares issued	33,000,000	33,000,000
Temporary equity shares outstanding	33,000,000	33,000,000
Common Class B [Member]
Class of Stock [Line Items]
Common stock shares authorized	50,000,000	50,000,000
Common stock par value per share	$ 0.0001	$ 0.0001
Common stock shares issued	8,250,000	8,250,000
Common stock shares outstanding	8,250,000	8,250,000
Common stock, Conversion basis	one-for-one basis

Warrants - Additional Informati

Warrants - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2022$ / shares
Class of Warrant or Right [Line Items]
Share price	$ 10
Percentage of capital raised for business combination to total equity proceeds	60.00%
Number of consecutive trading days for determining share price	10 days
Share Price Less Than or Equals To USD 9.2 [Member]
Class of Warrant or Right [Line Items]
Share price	$ 9.2
Class of warrants, exercise price adjustment percentage	115.00%
Share Price Less Than or Equals To USD 18 [Member]
Class of Warrant or Right [Line Items]
Share price	$ 18
Number of consecutive trading days for determining share price	20 days
Class of warrants, exercise price adjustment percentage	180.00%
Class of warrants, redemption notice period	30 days
Number of trading days for determining share price	30 days
Share Price Less Than or Equals To USD 18 [Member] | Class A Common Stock [Member]
Class of Warrant or Right [Line Items]
Share price	$ 10
Number of consecutive trading days for determining share price	20 days
Class of warrants, redemption price per unit	$ 0.1
Class of warrants, redemption notice period	30 days
Number of trading days for determining share price	30 days
Share Price More Than or Equals To USD 18 [Member] | Class A Common Stock [Member]
Class of Warrant or Right [Line Items]
Share price	$ 18
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants exercisable term from the date of completion of business combination	30 days
Warrants and rights outstanding, term	5 years
Minimum lock in period for SEC registration from date of business combination	20 days
Minimum lock In period to become effective after the closing of the initial Business Combination	60 days
Public Warrants [Member] | Share Price Less Than or Equals To USD 18 [Member]
Class of Warrant or Right [Line Items]
Share price	$ 18
Class of warrants, redemption price per unit	0.01
Public Warrants [Member] | IPO [Member]
Class of Warrant or Right [Line Items]
Class of warrant exercise price	11.5
Public Warrants [Member] | IPO [Member] | Class A Common Stock [Member]
Class of Warrant or Right [Line Items]
Class of warrant exercise price	$ 11.5

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Assets, Fair Value Disclosure [Abstract]
Assets Held-in-trust, Noncurrent	$ 330,174,862	$ 330,082,791
Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Assets Held-in-trust, Noncurrent	330,174,862	330,082,791
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	5,169,040	9,024,880
Fair Value, Recurring [Member] | Public Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	2,706,000	4,750,680
Fair Value, Recurring [Member] | Private Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	2,463,040	4,274,200
Level 1 [Member] | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Assets Held-in-trust, Noncurrent	330,174,862	330,082,791
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	2,706,000	4,750,680
Level 1 [Member] | Fair Value, Recurring [Member] | Public Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	2,706,000	4,750,680
Level 1 [Member] | Fair Value, Recurring [Member] | Private Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	0	0
Level 2 [Member] | Fair Value, Recurring [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	0	0
Level 2 [Member] | Fair Value, Recurring [Member] | Public Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	0	0
Level 2 [Member] | Fair Value, Recurring [Member] | Private Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	0	0
Level 3 [Member] | Fair Value, Recurring [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	2,463,040	4,274,200
Level 3 [Member] | Fair Value, Recurring [Member] | Public Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	0	0
Level 3 [Member] | Fair Value, Recurring [Member] | Private Warrants [Member]
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	$ 2,463,040	$ 4,274,200

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share Price	$ 10
Level 3 [Member] | Measurement Input, Share Price [Member] | Private Placement Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share Price	9.77	$ 9.71
Level 3 [Member] | Measurement Input, Exercise Price [Member] | Private Placement Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Strike price	$ 11.5	$ 11.5
Level 3 [Member] | Measurement Input, Expected Term [Member] | Private Placement Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Term (in years)	5 years	4 years 3 months
Level 3 [Member] | Measurement Input, Price Volatility [Member] | Private Placement Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Volatility	7.00%	14.00%
Level 3 [Member] | Measurement Input, Risk Free Interest Rate [Member] | Private Placement Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk-free rate	2.55%	1.40%
Level 3 [Member] | Measurement Input, Expected Dividend Rate [Member] | Private Placement Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Dividend yield	0.00%	0.00%

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Reconciliation of Changes in Fair Value Liability of Warrants Classified to Level 3 (Detail) - Level 3 [Member] - USD ($)		3 Months Ended	12 Months Ended
		Mar. 31, 2022	Dec. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value		$ 4,274,200	$ 0
Initial Measurement on March 12, 2021			17,421,333
Public Warrant reclassified to level 1	[1]		(8,844,000)
Change in fair value		(1,811,160)	(4,303,133)
Fair value		$ 2,463,040	$ 4,274,200
[1]	Assumes the Public Warrants were reclassified on March 31, 2021.

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Fair Value of the Derivative Warrant Liabilities (Detail) - Level 3 [Member] - USD ($)	3 Months Ended	12 Months Ended	13 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2021
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement		$ 17,421,333
Fair Value, Recurring [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement			$ 17,421,333
Change in valuation inputs or other assumptions	$ (3,855,840)		(8,396,453)
Ending balance	5,169,040	9,024,880	9,024,880
Public Warrants [Member] | Fair Value, Recurring [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement			9,108,000
Change in valuation inputs or other assumptions	(2,044,680)		(4,357,320)
Ending balance	2,706,000	4,750,680	4,750,680
Private Placement Warrants [Member] | Fair Value, Recurring [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement			8,313,333
Change in valuation inputs or other assumptions	(1,811,160)		(4,039,133)
Ending balance	$ 2,463,040	$ 4,274,200	$ 4,274,200

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - Subsequent Event [Member] - Promissory Note With Related Party [Member]	Apr. 11, 2022USD ($)$ / shares
Subsequent Event [Line Items]
Maximum Borrowing Capacity Of Related Party Promissory Note	$ 1,500,000
Debt Instrument, Maturity Date	Mar. 12, 2023
Maximum Loans Convertible Into Warrants	$ 1,500,000
Class Of Warrant Or Right Price Of Warrants Or Rights | $ / shares	$ 1.5